Sector portfolio · Private equity · United States
Sands Capital Ventures' Biotech portfolio
Sands Capital Ventures has backed 17 Biotech startups in rounds we track, $2.1B between them, shown by the stage each has reached. The best-funded is Taysha Gene Therapies.
Sands Capital Ventures's whole portfolioSands Capital Ventures's profile
Funding by segment
- Stage not reported$1.0B8
- Series C and later$828M7
- Series B$230M2
Where they are based
- United States15$1.8B
- Ireland2$230M
United States
IrelandFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M2
- $10M to $50M3
- $50M to $250M10
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
16 of 17 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States15
- Ireland2
Startups by country, 2 countries in all.
Segment by segment
Stage not reported
8 startups · $1.0B raised
Taysha Gene TherapiesTaysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.United States$400M- DTDice TherapeuticsDice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.United States$345M
Acrivon TherapeuticsAcrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.United States$130M
TeckroTeckro is an enterprise software company founded in 2015, headquartered in Limerick, Ireland, with additional offices in Dublin anIreland$60M
Alamar BiosciencesAlamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time.United States$50M- DZDay Zero DiagnosticsUnited States$25M
Firefly BioWorksFirefly BioWorks offers an open platform for industrial, academic, and clinical scientists to develop and use multiplexed biological assays.United States$3.4M
Nanoview BiosciencesNanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine.United States$2.5M
Series C and later
7 startups · $828M raised
908 Devices908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.United States$168M
RayzeBioRayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.United States$160M
Allotera TherapeuticsAllotera Therapeutics is a clinical-stage biotechnology company based in St.United States$150M
ArcherDXArcherDX is a biotechnology firm specializing in cancer research.United States$150M
Complete GenomicsComplete Genomics, a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis.United States$104M
SeLux DiagnosticsSeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.United States$48M- KCKit CheckUnited States$48M
Series B
2 startups · $230M raised
FIRE1FIRE1, officially known as The Foundry Innovation and Research 1, Ltd., is a connected medical device company based in Dublin, Ireland.Ireland$170M
Avenzo TherapeuticsDeveloping the next generation of oncology therapies for patients.United States$60M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Sands Capital Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Sands Capital Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.